Telisotuzumab Vedotin

About

Therapy type: Targeted therapy

Therapy strategy: MET inhibition

Mappings

NCI Thesaurus: Telisotuzumab Vedotin (coding:ncit:C118571)

RxNorm: telisotuzumab vedotin (coding:rxcui:2721996, coding:omop:37354008)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organizations Biomarkers Cancer types Therapies
FDA (1) c-Met >= 50% Lung Non-Squamous Non-Small Cell Carcinoma Telisotuzumab Vedotin